Securities ▲▼ | Shares | Value ($K) | |||||
|---|---|---|---|---|---|---|---|
Q4 2024 ▲▼ | Q1 2025 ▲▼ | Change ▲▼ | Q4 2024 ▲▼ | Q1 2025 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| SPDR GOLD TR(GLD) | 1,169 | 1,298 | +129 | 283 | 374 | 7.36% | +91 |
| COMPASS THERAPEUTICS INC(CMPX) | 43,465 | 43,465 | 0 | 63 | 83 | 1.63% | +20 |
| ADICET BIO INC | 17,488 | 17,488 | 0 | 17 | 13 | 0.26% | -4 |
| CONTEXT THERAPEUTICS INC(CNTX) | 18,403 | 18,403 | 0 | 19 | 11 | 0.22% | -8 |
| CARDIFF ONCOLOGY INC(CRDF) | 13,287 | 13,287 | 0 | 58 | 42 | 0.82% | -16 |
| INHIBIKASE THERAPEUTICS INC(IKT) | 16,393 | 16,393 | 0 | 53 | 36 | 0.71% | -17 |
| MIND MEDICINE MINDMED INC | 34,073 | 34,073 | 0 | 237 | 199 | 3.92% | -38 |
| KYVERNA THERAPEUTICS INC(KYTX) | 22,981 | 22,981 | 0 | 86 | 44 | 0.87% | -42 |
| BICARA THERAPEUTICS INC | 10,941 | 10,941 | 0 | 191 | 143 | 2.81% | -48 |
| GLYCOMIMETICS INC | 203,578 | 0 | -203,578 | 51 | 0 | — | -51 |
| LEXEO THERAPEUTICS INC(LXEO) | 17,851 | 17,851 | 0 | 117 | 62 | 1.22% | -56 |
| BERKSHIRE HATHAWAY INC DEL | 1,133 | 467 | -666 | 514 | 249 | 4.90% | -265 |
| SPDR S&P 500 ETF TR(SPY) | 2,823 | 0 | -2,823 | 1,654 | 0 | — | -1,654 |
| REZOLUTE INC(RZLT) | 1,318,967 | 1,318,967 | 0 | 6,463 | 3,825 | 75.28% | -2,638 |
| XERIS BIOPHARMA HOLDINGS INC | 2,015,157 | 0 | -2,015,157 | 6,831 | 0 | — | -6,831 |